Question

An outcome in the cancer experiment is measured by a test for the presence of cells...

An outcome in the cancer experiment is measured by a test for the presence of cells that trigger an immune response in the body and so may help fight cancer. Here are the data of 11 subjects: counts of active cells per 100,000 cells before and after infusion of thee modified cells. The difference ( after minus before) is the response variable. Before 14 0 1 0 0 0 0 20 1 6 0 After 41 7 1 215 20 700 13 530 35 92 108 Difference 27 7 0 215 20 700 13 510 34 86 108

a). Do the data give an evidence that the count of active cells is higher after treatment ?

b). Construct a 95% confidence interval for the data ?

Homework Answers

Answer #1
Before after d= before- after (d-dbar)^2
14
0
1
0
0
0
0
20
1
6
0
41
7
1
215
20
700
13
530
35
92
108

27
7
0
215
20
700
13
510
34
86
108

M: 156.36

16734.95
22309.5
24449.59
3438.22
18595.04
295540.5
20553.13
125058.68
14972.86
4951.04
2339.04

S: 548942.55

​​​​​

Know the answer?
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for?
Ask your own homework help question
Similar Questions
There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and that...
There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and that they can be harnessed to use the body's immune system to treat cancer. One study investigated the use of a T cell-engaging antibody, blinatumomab, to recruit T cells to control tumor growth. The data below are T cell counts (1000 per microliter) at baseline (beginning of the study) and after 20 days on blinatumomab for 6 subjects in the study. The difference (after 20...
There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and that...
There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and that they can be harnessed to use the body's immune system to treat cancer. One study investigated the use of a T cell-engaging antibody, blinatumomab, to recruit T cells to control tumor growth. The data below are T cell counts (1000 per microliter) at baseline (beginning of the study) and after 20 days on blinatumomab for 6 subjects in the study. The difference (after 20...
(20.48) There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and...
(20.48) There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and that they can be harnessed to use the body's immune system to treat cancer. One study investigated the use of a T cell-engaging antibody, blinatumomab, to recruit T cells to control tumor growth. The data below are T cell counts (1000 per microliter) at baseline (beginning of the study) and after 20 days on blinatumomab for 6 subjects in the study. The difference (after...
A study was performed on melanoma patients who had not responded to existing treatments to see...
A study was performed on melanoma patients who had not responded to existing treatments to see if a new genetic engineering technique could help fight cancer. The outcome of this treatment is measured by the number of active cells that can trigger an immune response in the body. The number of active cells per 100,000 cells was recorded before and after treatment for each patient in the following table. Before 14 0 1 0 0 15 0 2 4 0...
There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and that...
There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and that they can be harnessed to use the body's immune system to treat cancer. One study investigated the use of a T cell‑engaging antibody, blinatumomab, to recruit T cells to control tumor growth. Given are the T cell counts (1000 per microliter) at baseline (beginning of the study) and after 20 days on blinatumomab for six subjects in the study. The difference, after 20 days...
There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and that...
There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and that they can be harnessed to use the body's immune system to treat cancer. One study investigated the use of a T cell‑engaging antibody, blinatumomab, to recruit T cells to control tumor growth. Given are the T cell counts (10001000 per microliter) at baseline (beginning of the study) and after 2020 days on blinatumomab for six subjects in the study. The difference, after 2020 days...
1. Multiple myeloma, or blood plasma cancer is characterized by increased blood vessel formulation (angiogenesis) in...
1. Multiple myeloma, or blood plasma cancer is characterized by increased blood vessel formulation (angiogenesis) in the bone marrow that is a predictive factor in survival. One treatment approach used for multiple myeloma is stem cell transplantation with the patient’s own stem cells. The data in the table below represent the bone marrow micro-vessel density for patients who had a complete response to the stem cell transplant and at the time the complete response was determined. Patient Before After     ...
Multiple myeloma, or blood plasma cancer, is characterized by increased blood vessel formulation (angiogenesis) in the...
Multiple myeloma, or blood plasma cancer, is characterized by increased blood vessel formulation (angiogenesis) in the bone marrow that is a predictive factor in survival. One treatment approach used for multiple myeloma is stem cell transplantation with the patient's own stem cells. The data show below represents the bone marrow microvessel density for patients who has a complete response to the stem cell transplant (as measured by blood and urine tests). The measurements were taken immediately prior to the stem...
What is the F-critical value for a one-tail F-test if the numerator sample size is 21...
What is the F-critical value for a one-tail F-test if the numerator sample size is 21 (n1) and the denominator sample size is 16 (n2); use level of significance (α) 0.05. Select one: a. 3.37 b. -3.99 c. 2.33 d. 3 To test the effectiveness of a business school preparation course, 8 students took a general business test before and after the course. The results are given below.                     Exam Score              Exam Score Student   Before Course (1)       After Course (2)...
1. An antigen is A. a molecule that can elicit an immune response. B. a nucleic...
1. An antigen is A. a molecule that can elicit an immune response. B. a nucleic acid only. C. a protein or nucleic acid. D. a protective protein that the immune system produces. 2. The human leukocyte antigen genes are on the A. short arm of chromosome 6. B. long arm of chromosome 18. C. short arm of chromosome 2. D. long arm of chromosome 6. 3. Identifying combinations of _____ alleles is useful in tissue typing, establishing identity, and...
ADVERTISEMENT
Need Online Homework Help?

Get Answers For Free
Most questions answered within 1 hours.

Ask a Question
ADVERTISEMENT